University of Missouri
105 Jesse Hall, Columbia, MO, 65211, United States
Overview
University of Missouri (also known as Mizzou) in Columbia, Missouri, is one of the oldest public universities in the region. Today Mizzou has grown to offer more than 280 degree programs at the undergraduate and graduate levels, including those in medicine and other advanced professional fields. As a full-fledged university with much in the way of academics, research and college life offerings, Mizzou’s more than 30,000 students come from all over the country. Some of the more popular programs at the school include Journalism and Writing. Mizzou is also one of a small group of universities that offers Medicine, Law and Veterinary Medicine. Additional divisions include: *Agriculture *Arts and Sciences *Business *Education *Engineering *Nursing More than 600 student organizations also make their home at Mizzou, so that whatever a student’s interest is it can be found at Mizzou. In order to maintain itself as the competitive public university that it is, Mizzou has had to maintain fairly selective standards for admission. A great number of admitted students were valedictorians of their class or graduated in the top 10%. Mizzou considers grade point average, rigor of high school courses, SAT or ACT scores and other factors such as extracurricular involvement in its undergraduate admissions process. Graduate programs have individual requirements that may include course pre-requisites, undergraduate GPA and test scores. Students may be considered for academic merit scholarships awarded by the school. There are also federal aid sources such as Pell grants, loans and work-study to help those with a financial need to cover tuition costs. Veteran’s benefits are also offered.
- Total investments
- 2
- Lead investments
- 0
- Investments · 12mo
- 1
- Active investors
- 8
Sector focus
- Education
- Higher Education
- Universities
Investment portfolio
- RouteSense
Participated · Seed · Jan 2026
RouteSense provides a unified intelligence layer that consolidates fragmented payment data across the transaction lifecycle, giving stakeholders near-real-time insight into merchant identification (MID) health. Its debut product, Pathfinder, continuously monitors network-defined health indicators and dynamically routes transactions to the healthiest MIDs, helping merchants maintain authorization performance and comply with Visa’s new Visa Acquiring Monitoring Program (VAMP). Unlike legacy reporting tools that surface issues weeks later, Pathfinder offers predictive analytics that enable proactive intervention before fines or account holds occur. The platform is powered by a modern data infrastructure and is designed to expand across the full payment lifecycle, ultimately becoming the operating intelligence layer for acquirers worldwide. RouteSense was founded by industry veterans Stephen Martin, Robert Matthews, and Colin Martin, who collectively bring more than 75 years of payments and real-time analytics experience. The company is currently onboarding select merchants, payment service providers, and processors. Future plans include adding continuous portfolio visibility, predictive risk signals, and end-to-end MID health management capabilities.
- Nucleus RadioPharma
Participated · Series A · Oct 2023
Nucleus RadioPharma manufactures radiopharmaceuticals and manages the time-sensitive logistics required to deliver those radioactive cancer therapies to hospitals before they decay. Founded in late 2022 and launched in 2023 with a $56 million Series A, the company opened its Rochester manufacturing facility on the Mayo Clinic campus and plans a second regional hub outside Philadelphia. Its strategy centers on expanding regional manufacturing capacity to address supply-chain bottlenecks caused by short half-lives of radioactive isotopes. The recent $50 million financing from OrbiMed will fund further expansion at Rochester and construction of the Philadelphia-area site. Nucleus currently employs 56 full-time staff and is hiring as it ramps toward full operations, aiming to have the new regional center operational by 2028.